Sentinel node in head and neck cancer: use of size criterion to upstage the no neck in head and neck squamous cell carcinoma

Head Neck. 2007 Feb;29(2):95-103. doi: 10.1002/hed.20486.

Abstract

Background: Anatomical imaging tools demonstrate poor sensitivity in head and neck squamous cell carcinoma (HNSCC) patients with clinically node-negative necks (cN0). This study evaluates nodal size as a staging criterion for detection of cervical metastases, utilizing sentinel node biopsy (SNB) and additional pathology (step-serial sectioning, SSS; and immunohistochemistry, IHC).

Methods: Sixty-five patients with clinically N0 disease underwent SNB, with a mean of 2.4 nodes excised per patient. Nodes were fixed in formalin, bisected, and measured in 3 axes before hematoxylin-eosin staining. Negative nodes were subjected to SSS and IHC. SNB-positive patients underwent modified radical neck dissection.

Results: Maximum diameter was larger in levels II and III (13.1 and 13.2 mm) when compared with level I (10.5 mm; p = .004, p = .018), while minimum diameter was constant. Positive nodes were larger than negative nodes (p = .007), but nodes found positive by SSS/IHC were not significantly larger than negative nodes for either measurement (p = .433). Sensitivity and specificity were poor for all measurements.

Conclusions: Nodal size is an inaccurate predictor of nodal metastases and should not be regarded as an accurate means of staging the clinically N0 neck.

MeSH terms

  • Carcinoma, Squamous Cell / pathology*
  • Head and Neck Neoplasms / pathology*
  • Humans
  • Immunohistochemistry
  • Lymph Node Excision
  • Lymph Nodes / pathology*
  • Neck Dissection
  • Neoplasm Staging
  • Sensitivity and Specificity
  • Sentinel Lymph Node Biopsy*